
HKSEHealthcareMedical - Pharmaceuticals
最新数据
HK$0.865
+HK$0.025 · +2.98%
Regent Pacific Group Limited is an investment holding company that primarily focuses on the healthcare and life sciences sectors. The company is involved in the research, development, and sale of pharmaceutical products, with a notable focus on treatments for urological disorders. It also invests in a portfolio of both listed and unlisted corporate entities.
最新数据
HK$0.865
+HK$0.025 · +2.98%
Regent Pacific Group Limited is an investment holding company that primarily focuses on the healthcare and life sciences sectors. The company is involved in the research, development, and sale of pharmaceutical products, with a notable focus on treatments for urological disorders. It also invests in a portfolio of both listed and unlisted corporate entities.
52周区间
当前HK$0.865
Regent Pacific Group Limited is an investment holding company that primarily focuses on the healthcare and life sciences sectors. The company is involved in the research, development, and sale of pharmaceutical products, with a notable focus on treatments for urological disorders. It also invests in a portfolio of both listed and unlisted corporate entities.
52周区间
当前HK$0.865
近期已公布业绩
近期已公布业绩
年度分割调整后的每股现金分配。
HK$26.00
2013年(完整年度)+358.2% 自从 2005
HK$5.674
2,005
HK$2.00
2,010
HK$4.00
2,011
HK$6.00
2,012
HK$26.00
2,013
| 行动 | 除息日 | 详情 | 记录日期 | 付款日期 |
|---|---|---|---|---|
股息 | 2013年2月8日 | HK$0.0007Annual | — | — |
股息 | 2012年1月16日 | HK$0.0002Annual | — | — |
股息 | 2011年1月4日 | HK$0.0001Semi-Annual | — | — |
股息 | 2010年6月3日 | HK$0.0001Special | — | — |
股息 | 2005年11月14日 | HK$0.0003Special | — | — |
股息 | 2004年8月19日 | HK$0.0003Special | — | — |
除息 2013年2月8日
HK$0.0007
Annual
除息 2012年1月16日
HK$0.0002
Annual
除息 2011年1月4日
HK$0.0001
Semi-Annual
除息 2010年6月3日
HK$0.0001
Special
除息 2005年11月14日
HK$0.0003
Special
除息 2004年8月19日
HK$0.0003
Special
AI 生成内容及延迟市场数据仅供信息与教育用途,不构成投资建议。